SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18042296
Source:
http://linkedlifedata.com/resource/pubmed/id/18042296
Search
Subject
(
85
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0021467
,
umls-concept:C0021469
,
umls-concept:C0034634
,
umls-concept:C0038952
,
umls-concept:C0086272
,
umls-concept:C0243026
,
umls-concept:C0442805
,
umls-concept:C1366622
,
umls-concept:C1514468
,
umls-concept:C1719672
pubmed:issue
6
pubmed:dateCreated
2008-2-19
pubmed:abstractText
The receptor for advanced glycation end products (RAGE), a multi-ligand member of the immunoglobulin superfamily, contributes to acute and chronic disease processes, including sepsis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-10399917
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-10772656
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-10835680
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-10966490
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-11108954
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-11581294
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-11854121
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-11865436
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-12070776
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-12222959
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-12639085
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-12974876
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-1321822
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-1378843
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-14467923
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-14623906
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-14660645
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-14695889
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-15173835
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-15173891
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-15660511
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-16858429
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-18190725
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-2246512
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18042296-7592757
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9801902
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Glycosylation End Products, Advanced
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Immunologic
,
http://linkedlifedata.com/resource/pubmed/chemical/advanced glycosylation end-product...
pubmed:status
MEDLINE
pubmed:issn
1466-609X
pubmed:author
pubmed-author:ClancyBrian MBM
,
pubmed-author:KeithJames CJCJr
,
pubmed-author:KessimianNoubarN
,
pubmed-author:LutterlohEmily CEC
,
pubmed-author:MilarskiKimK
,
pubmed-author:OpalSteven MSM
,
pubmed-author:PalardyJohn EJE
,
pubmed-author:PalmerHelenH
,
pubmed-author:ParejoNicholas ANA
,
pubmed-author:PittmanDebra DDD
,
pubmed-author:SunYingY
,
pubmed-author:TanXiang-YangXY
pubmed:issnType
Electronic
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
R122
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18042296-Animals
,
pubmed-meshheading:18042296-Antibodies, Monoclonal
,
pubmed-meshheading:18042296-Disease Models, Animal
,
pubmed-meshheading:18042296-Glycosylation End Products, Advanced
,
pubmed-meshheading:18042296-Listeriosis
,
pubmed-meshheading:18042296-Male
,
pubmed-meshheading:18042296-Mice
,
pubmed-meshheading:18042296-Mice, Inbred BALB C
,
pubmed-meshheading:18042296-Mice, Knockout
,
pubmed-meshheading:18042296-Receptors, Immunologic
,
pubmed-meshheading:18042296-Sepsis
,
pubmed-meshheading:18042296-Survival Rate
,
pubmed-meshheading:18042296-Systemic Inflammatory Response Syndrome
pubmed:year
2007
pubmed:articleTitle
Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection.
pubmed:affiliation
Division of Infectious Diseases, Memorial Hospital of Rhode Island, 111 Brewster St, Pawtucket, RI 02860, USA.
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, Non-U.S. Gov't